home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  December 22, 2024
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 460 active entries

National Disease Research Interchange (NDRI)

1601 Cherry Street, Suite 1700
Philadelphia, PA 19102 USA
United States of America, Pennsylvania
Toll free: 800-222-6374

Phone: 215-557-7361
Fax: 215-557-7154
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Description:

 

With over 40 years of experience, The National Disease Research Interchange (NDRI) is on the leading edge of the biomedical research resource value chain. NDRI is a world leader in providing human biospecimens to academic and corporate researchers from a diverse pool of normal and diseased donors to support the advancement of biomedical research.

Our nationwide network of organ and tissue donation organizations and hospitals allow NDRI to obtain biospecimens from all body systems. NDRI utilizes a collaborative procurement model to provide project-specific collection protocols that meet the experimental needs of each project. NDRI typically has around 1,000 investigator protocols active. NDRI is cited as the source for biospecimens in research findings published in an average of 150 scientific publications per year.


 



Selected Categories:
Product Company   Service Company
Biopharma
- Research
Biotech
- Research
Pharmaceutical
- Research
Supplier
- Research
Consulting
- Research
Contract
- Research

Last update of this entry: October 29, 2024

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.